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Regulated Release of L13a from the 60S Ribosomal
Subunit as A Mechanism of Transcript-Specific
Translational Control
inflammatory process is not well-controlled or resolved
in a timely fashion, it can lead to host tissue damage
(Nathan, 2002).
Ceruloplasmin (Cp) is an acute phase protein synthe-
sized and secreted systemically into plasma by hepato-
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cytes, and locally in inflammatory sites by cytokine-stimu-Lerner Research Institute
lated macrophages (Fleming et al., 1991; Mazumder etCleveland Clinic Foundation
al., 1997). Cp contains 6–7 copper atoms per molecule9500 Euclid Avenue
and utilizes them for diverse oxidative functions (BielliCleveland, Ohio 44195
and Calabrese, 2002). By virtue of its ferroxidase activity3 Department of Biology
that facilitates iron loading into transferrin, liver-derivedCleveland State University
plasma Cp has an important role in plasma iron homeo-2121 Euclid Avenue
stasis (Osaki et al., 1966). In the absence of Cp, forCleveland, Ohio 44115
example in patients with hereditary Cp deficiency,
pathological iron accumulation leads to neural defects,
blindness, and diabetes (Gitlin, 1998). The function ofSummary
macrophage-derived Cp is less clear. A likely possibility
is bactericidal activity, possibly due to oxidative damageTranscript-specific translational control is generally
by Cp copper or to iron restriction (Klebanoff, 1992). Wedirected by binding of trans-acting proteins to struc-
and others have shown that Cp copper causes oxidativetural elements in the untranslated region (UTR) of the
modification of macromolecules, including low-densitytarget mRNA. Here, we elucidate a translational silenc-
lipoprotein (Mukhopadhyay et al., 1997). Cp-mediateding mechanism involving regulated release of an inte-
oxidation may underlie the observation that Cp is angral ribosomal protein and subsequent binding to its
independent risk factor for cardiovascular disease in-target mRNA. Human ribosomal protein L13a was
cluding atherosclerosis, carotid restenosis after endar-identified as a candidate interferon-Gamma-Activated
terectomy, and myocardial infarction (Salonen et al.,Inhibitor of Translation (GAIT) of ceruloplasmin (Cp)
1991; Mezzetti et al., 1999).mRNA by a genetic screen for Cp 3-UTR binding pro-
Consistent with a role of Cp in macrophage-mediatedteins. In vitro activity of L13a was shown by inhibition
host defense, interferon (IFN)- induces Cp mRNA andof target mRNA translation by recombinant protein. In
protein expression in U937 monocytic cells and periph-response to interferon- in vivo, the entire cellular pool
eral blood monocytes (Mazumder et al., 1997). We haveof L13a was phosphorylated and released from the
shown that Cp induction is subject to a unique transla-60S ribosomal subunit. Released L13a specifically
tional silencing mechanism in which synthesis is selec-bound the 3-UTR GAIT element of Cp mRNA and si-
tively terminated about 16 hr after IFN- treatment, evenlenced translation. We propose a model in which the
in the presence of abundant Cp mRNA (Mazumder andribosome functions not only as a protein synthesis
Fox, 1999). A 29 nt, IFN-gamma-activated inhibitor ofmachine, but also as a depot for regulatory proteins
translation (GAIT) element in the Cp 3-untranslated re-that modulate translation.
gion (UTR) is necessary for IFN--mediated translational
silencing of Cp, and is sufficient to convey the silencingIntroduction
response to a heterologous transcript (Sampath et al.,
2003). We have also shown that translational silencing
Most studies of acute or chronic inflammatory disease
of Cp requires the essential elements of mRNA circular-
processes focus on the causes of inflammation, e.g., ization; removal or inactivation of any of the components
microbial infection, imbalance of proinflammatory cyto- of end-to-end transcript closure, i.e., the poly(A) tail,
kines, and disturbance of proinflammatory signaling eukaryotic initiation factor (eIF) 4G, or poly(A) binding
pathways. Because of this emphasis, much more is protein (PABP), prevents translational silencing (Ma-
known about processes that initiate and sustain inflam- zumder et al., 2001). Finally, we have shown delayed
mation than about processes that limit or terminate it. appearance of a cytosolic protein (or complex) in IFN--
Understanding the latter processes are important be- treated U937 cells that specifically binds the GAIT ele-
cause defects may contribute to inflammatory disease ment. On the basis of these results, we have proposed
progression, and because these processes present al- a mechanism of translational control in which Cp mRNA
ternative targets for therapy. Monocyte-derived macro- circularization brings a cytosolic, 3-UTR binding inhibi-
phages, by virtue of their antimicrobial activity and their tor protein (GAIT) into the proximity of the 5-UTR where
clearance of toxic debris, have a central role in inflamma- it blocks the initiation of translation (Mazumder et al.,
tion. Activation of these cells depends on a complex 2001, 2003).
suite of interactions with cytokines, and the consequent Here, we identify ribosomal protein L13a as GAIT, a
induction of specific genes that produce a toxic micro- molecular switch of the translational silencing event that
environment for the invading organism. However, if the blocks Cp expression. We further show that IFN- in-
duces delayed phosphorylation of L13a and causes un-
coupling of L13a from the large ribosomal subunit. The*Correspondence: foxp@ccf.org
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released L13a binds to the GAIT element in the Cp 3- Luc-Cp 3-UTR(50–150)-poly(A) translation and by specific
binding to radiolabeled Cp 3-UTR probe (data notUTR and silences Cp mRNA translation.
shown). These results indicate that the ORF2 protein
product is responsible for the observed silencing ac-Results
tivity.
Sequence analysis of the ORF2 plasmid DNA showedIdentification of Ribosomal Protein L13a
that it encoded full-length human ribosomal proteinas a Candidate GAIT
L13a (Figure 1D). L13a, also known as mouse tum- trans-We have identified candidate GAIT cDNAs using the
plantation antigen P198, is an integral protein of theyeast three-hybrid screen. In this genetic method, the
large ribosomal subunit. It is a highly basic, 23 kDabinding of a bifunctional RNA to each of two-hybrid
protein containing 202 amino acids (Price et al., 1992).proteins activates transcription of a reporter gene in
Two consensus motifs have been described in L13avivo (SenGupta et al., 1996). This method has been used
(Figure 1E), a leucine zipper at the N terminus possiblyto detect and identify several specific RNA binding pro-
involved in homo- or heterodimerization and a basicteins (Martin et al., 1997). For bait we used an RNA
domain leucine zipper that may be involved in RNA orhybrid of the Cp 3-UTR spanning nt 50 to 150 (Cp 3-
DNA interactions (Chan et al., 1994). The role of L13a inUTR(50–150)) coupled with MS2 RNA. The prey was con-
ribosome function is not known, but it is not near thetained in a cDNA library from IFN--activated U937 cells
peptidyl transferase site or the peptide exit tunnel, andin tandem with a B42 activation domain. Binding of acti-
thus may not have a direct role in the formation of na-vation domain-tagged protein to the Cp 3-UTR(50–150) bait
scent proteins (Ban et al., 2000; Moore and Steitz, 2003).results in activation of HIS3 gene. 106 clones were
screened to yield 103 primary positive clones. These
clones were further screened for Cp 3-UTR-dependent L13a Binds the Cp 3-UTR GAIT Element in Cells
and Is Required for Translational Silencing ActivityHIS3 activation by their sensitivity to 5-fluoroorotic acid
(FOA). 5-FOA causes the rejection of the URA3-con- The binding of endogenous U937 cell L13a to the Cp
3-UTR GAIT element was examined in vitro by an RNAtaining bait plasmid, hence clones that depend on the
presence of bait RNA for the activation of HIS3 gene “supershift” assay using a rabbit polyclonal antihuman
L13a antibody prepared against a 16 amino acid peptidewill not be able to grow in 5-FOA-containing, histidine-
deficient medium. Sequencing of these clones identified near the C terminus (Figure 1D). Cytosolic extracts were
prepared from U937 cells treated with IFN- for 8 or 24fifteen 5-FOA-sensitive clones containing significant
open reading frames (ORFs) in-frame with the B42 acti- hr and incubated with radiolabeled, 29 nt GAIT element
as probe. As observed previously, an RNA-protein com-vation domain. The clones were replicated in uracil-
containing medium to reject the URA3-containing bait plex formed in the presence of lysates from cells treated
with the cytokine for 24 hr, but untreated cells or cellsRNA plasmid and to express RNA binding prey protein
in unbound form. Translational silencing activity of can- treated for 8 hr did not express binding activity (Ma-
zumder et al., 2001; Sampath et al., 2003; Mazumderdidate clones was assessed as the ability of yeast ly-
sates to inhibit in vitro translation of the chimeric re- and Fox, 1999). The complex formed by the 24 hr lysate
was supershifted by anti-L13a antibody indicating thatporter transcript, Luc-Cp 3-UTR(50–150)-poly(A) in a rabbit
reticulocyte lysate. A single clone, designated ORF2, L13a is in the GAIT element binding complex (Figure
2A). A minor complex was seen in some experimentsreproducibly inhibited translation of the reporter but did
not alter translation of a control transcript that lacked and was not shifted by the antibody. The translational
silencing activity of endogenous L13a in the cell lysatethe GAIT element, T7 gene 10 (Figure 1A). The interaction
of ORF2 with the Cp 3-UTR was shown by RNA electro- was tested by immunodepletion using anti-L13a anti-
body. Western analysis of the depleted extract showedphoretic mobility shift assay (EMSA) using radiolabeled
Cp 3-UTR(50–150) as probe (Figure 1B). Specific binding that essentially all L13a was removed (data not shown).
The extract was tested for its ability to inhibit translationwas shown by competition by a 25-fold molar excess
of in vitro-synthesized, 29 nt GAIT element (Cp 3- of the chimeric Luc-Cp 3-UTR(50–150)-poly(A) reporter
transcript in a reticulocyte lysate in vitro. As seen pre-UTR(78–106)), but not by excess GAIT element containing
the inactivating U87C mutation that blocks cis-acting viously, lysates from cells treated with IFN- for 24 hr,
but not for 8 hr, were inhibitory (Mazumder et al., 2001;translational silencing activity (Sampath et al., 2003)
(Figure 1B). These functional and binding activities of Sampath et al., 2003; Mazumder and Fox, 1999). Also,
the silencing activity was specific since it did not blockORF2 suggest that it is a likely GAIT candidate.
To verify that the observed activity was ORF2 plasmid- translation of the phage T7 gene 10 control transcript
that does not contain the GAIT element. Immunodeple-driven and not due to a secondary alteration or mutation
in the yeast clone, ORF2 plasmid DNA was recovered tion completely removed translational silencing activity
indicating that L13a is GAIT or a component of a GAITfrom the clone and retransformed in yeast with the bait.
Yeast cotransformed with vectors containing ORF2 and complex that silences Cp translation (Figure 2B).
The in vivo interaction between L13a and Cp mRNACp 3-UTR(50–150) grew in histidine-depleted, 3-AT-con-
taining media, but vector-transformed yeast did not in stimulated U937 cells was investigated. The cells were
treated with IFN- for 8 or 24 hr, extracts were prepared,grow (Figure 1C, middle). All transformants grew in histi-
dine-supplemented medium (Figure 1C, right). Transla- and L13a was immunoprecipitated with anti-L13a anti-
body. RNA was extracted from the immunoprecipitate,tional silencing activity was verified in lysates prepared
from yeast retransformed with ORF2 plasmid. The lysate and reverse-transcribed with oligo-dT and amplified by
PCR using primers specific for human Cp 3-UTR. A PCRcontained functional protein as shown by inhibition of
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Figure 1. Identification of a Candidate GAIT
by the Yeast Three-Hybrid Screen
(A) Inhibition of GAIT element-mediated
translation by ORF2. Capped, Luc-Cp 3-
UTR(50–150)-poly(A) cRNA was subjected to in
vitro translation in a reticulocyte lysate con-
taining [35S]methionine in the presence of cy-
tosolic extracts (4 g) from selected yeast
clones (ORFs 1–4), and from yeast trans-
formed with the vector (vect.) control.
Capped, T7 gene 10 cRNA, which lacks the
GAIT element, was added to each sample as
a loading and specificity control. Aliquots of
the translation reaction were subjected to
10% SDS-PAGE and autoradiography.
(B) Binding of yeast ORF2 protein to the GAIT
element. Lysate from the yeast clone con-
taining ORF2 was subjected to RNA EMSA
using radiolabeled Cp 3-UTR(50–150) as probe.
RNA-protein complexes were resolved by
electrophoresis on a nondenaturing 5% poly-
acrylamide gel and detected by autoradiog-
raphy. In competition experiment, the lysates
were preincubated with a 25-fold molar ex-
cess of unlabeled, 29 nt GAIT element, or the
U87C mutant element, before addition of ra-
diolabeled probe.
(C) Retransformation of yeast with ORF2 and
Cp 3-UTR restores survival in histidine-defi-
cient medium. Competent L40uraMS2 was
cotransformed with vectors expressing
ORF-2 as prey and Cp 3-UTR(50–150) as bait, or
with either one of these vectors plus control
vector (left). Transformed yeast were grown
either in histidine-deficient, 3-AT-containing
medium (center) or in histidine-containing
medium without 3-AT (right).
(D) Deduced amino acid sequence of human L13a obtained from the ORF-2 cDNA. Peptide used to raise a rabbit polyclonal antihuman L13a
antibody is underlined.
(E) Putative domain structure of human L13a.
fragment corresponding to the Cp 3-UTR was observed baculovirus-infected insect cells, and partially purified
by gel filtration chromatography. Both systems ex-only in the immunoprecipitate from cells treated with
IFN- for 24 hr (Figure 2C, left image). The identity of pressed substantial amounts of soluble recombinant
protein, but insect cell-derived protein had slightly re-the amplified product was confirmed by sequencing.
RT-PCR of extracts not subjected to immunoprecipita- tarded mobility compared to E. coli-derived protein,
suggesting a possible posttranslational modification bytion showed that cells treated with IFN- for either 8 or
24 hr expressed Cp mRNA, as expected, but that the insect cells (Figure 3A). E. coli-derived protein did not
affect in vitro translation of the chimeric reporter tran-transcript did not bind L13a in 8 hr extracts (Figure 2C).
As a control, no amplification product was seen in any script Luc-Cp 3-UTR(50–150)poly(A) (Figure 3B). However,
insect cell-generated L13a inhibited translation of theRNA sample not subjected to reverse-transcription (Fig-
ure 2C, second image). Specificity of the interaction was reporter transcript to about the same extent as an active
cytosolic extract from U937 cells treated with IFN- forshown by the absence of the RT-PCR product of Cp
mRNA in extracts immunoprecipitated with antibody 24 hr (Figure 3B). The silencing activity of recombinant
L13a was specific and did not block translation of theagainst another ribosomal protein, L28 (Figure 2C, third
image). To show equal recovery of RNA from immuno- phage T7 gene 10 control transcript (Figure 3B).
precipitated samples, glyceraldehyde-3-phosphate de-
hydrogenase (GAPDH) mRNA, a nonspecific, high-abun- IFN- Causes Delayed Phosphorylation
of L13a in U937 Cellsdance transcript, was amplified using additional PCR
cycles (Figure 2C, right image). Taken together, these Our finding that L13a does not bind the target transcript,
or block its translation, until 8 to 24 hr of IFN- treatmentresults show that L13a binds specifically, and in a de-
layed fashion, to the Cp 3-UTR in IFN--treated U937 suggests a delayed induction or activation of the protein.
To examine the effect of IFN- on L13a expression, U937cells.
cells were incubated with IFN- for 8 or 24 hr and RNA
was isolated and subjected to Northern analysis usingRecombinant L13a Has Translational
Silencing Activity radiolabeled, full-length L13a cDNA as probe. IFN-
treatment did not alter the steady-state level of L13aThe translational silencing activity of L13a was tested
using recombinant protein expressed in E. coli and in mRNA during this treatment period (Figure 4A). To exam-
Cell
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Figure 2. Endogenous U937 Cell L13a Binds
to GAIT Element and Is Required for Transla-
tional Silencing
(A) RNA EMSA supershift analysis shows
L13a in GAIT element binding complex in
U937 cells. U937 cells were treated with IFN-
for 8 or 24 hr and cytosolic extracts were
incubated with radiolabeled, 29 nt GAIT ele-
ment. To show the presence of L13a, the 24
hr extract was preincubated with polyclonal
rabbit antihuman L13a antibody or with pre-
immune serum (Pre-im.) before addition of
radiolabeled probe. Shifted complex is indi-
cated (open arrow).
(B) Immunodepletion of L13a removes trans-
lational silencing activity from U937 cell ly-
sates. Cytosolic extracts were made from
U937 cells treated with IFN- for 8 or 24 hr.
The 24 hr extract was immunodepleted with
anti-L13a antibody or with preimmune serum
as control. The effect of extracts on in vitro
translation of capped, Luc-Cp 3-UTR(50–150)-
poly(A) cRNA was determined by addition to
a reticulocyte lysate containing [35S]methio-
nine. Capped, T7 gene 10 cRNA was added
to each reaction as a specificity control.
(C) Demonstration of intracellular binding of L13a to Cp mRNA in U937 cells by immunoprecipitation (IP) and RT-PCR. U937 cells were treated
with IFN- for 8 or 24 hr. Aliquots of the cytosolic extracts were subjected to immunoprecipitation with rabbit antihuman L13a antibody (Ab).
RNA was extracted from the immunoprecipitate or from extracts not subjected to immunoprecipitation (No IP). RNA was subjected to reverse
transcription with Superscript (Invitrogen) and oligo-dT, and then to PCR amplification with primers specific for the Cp 3-UTR (left image) or
GAPDH (right image). In other controls, the Cp 3-UTR was amplified by PCR in the absence of the RT reaction (second image), and Cp 3-
UTR was amplified in cytosolic extracts that were immunoprecipitated with anti-L28 antiserum or with preimmune serum (third image).
ine posttranscriptional regulation, extracts from IFN-- translational silencing activity (data not shown). To con-
firm the role of L13a phosphorylation in translationaltreated U937 cells were subjected to immunoblot analy-
sis with anti-L13a antibody. IFN- treatment did not silencing activity, we considered the possibility that the
difference in activity (and electrophoretic mobility) ofsignificantly alter L13a expression level; however, the
electrophoretic mobility of L13a was markedly de- recombinant L13a protein from two sources was due to
differential phosphorylation. Metabolic labeling with 32P-creased after treatment with the cytokine for 24 hr, sug-
gesting a possible delayed posttranslational modifica- orthophosphate and immunoprecipitation with anti-
L13a antibody revealed that active, insect cell-derivedtion (Figure 4B).
In view of the regulation of RNA binding activity of L13a was phosphorylated, whereas inactive, E. coli-
derived protein was unmodified (Figure 4F). Treatmentseveral proteins by phosphorylation (Dominski et al.,
2002; Law et al., 2003; Zhang et al., 2003; Ostrowski et of insect cell-derived L13a with alkaline phosphatase
increased the electrophoretic mobility of the proteinal., 2000; Ostareck-Lederer et al., 2002; Siomi et al.,
2002), we considered the possibility that L13a phosphor- (data not shown) and blocked its silencing activity (Fig-
ure 4G). Our results show that the entire U937 cellularylation was responsible for the observed shift in electro-
phoretic mobility. L13a phosphorylation was measured pool of L13a is phosphorylated after prolonged IFN-
treatment, and that the modification is required for trans-by metabolic labeling with a 6 hr pulse of 32P-orthophos-
phate followed by immunoprecipitation with anti-L13a lational silencing activity.
antibody, SDS-PAGE separation, and autoradiography.
L13a was phosphorylated with a time course consistent IFN- Induces Release of L13a from the 60S
Ribosomal Subunitwith its mobility shift (Figure 4C). To test the role of
phosphorylation, we determined the effect of phospha- Our findings raise a question about the form of L13a
that binds the target transcript, namely, whether L13atase treatment on L13a activity. U937 cells were treated
with IFN- and active, 24 hr lysates were incubated with remains associated with the large ribosomal subunit or
is present in a cytosolic, nonribosomal form after IFN-alkaline phosphatase. Immunoblot analysis showed that
the phosphatase restored the original electrophoretic treatment. Lysates from IFN--treated U937 cells were
fractionated on a sucrose cushion to separate the ribo-mobility of L13a, indicating that the shift was due to
phosphorylation and also showing effectiveness of the somal fraction from ribosome-free cytosol (Mazumder
and Fox, 1999; Wormington, 1991). Both fractions weretreatment (Figure 4D). The phosphatase-treated lysate
did not inhibit in vitro translation of the Luc-Cp 3-UTR(50– subjected to SDS-PAGE and immunoblot analysis with
anti-L13a antibody. L13a was primarily in the ribosome150)-poly(A) reporter, indicating a critical role of L13a
phosphorylation in silencing activity (Figure 4E). Addi- fraction of untreated cells or cells treated with IFN- for
8 hr (Figure 5A). In contrast, after 24 hr, L13a was presenttion of phosphatase inhibitor (cocktail set II at a 1:100
dilution plus 5 mM levamisole) with the phosphatase only in the ribosome-free, low-molecular weight fraction
(and primarily in the phosphorylated form). As a controlprevented the mobility shift of L13a and restored its
Release of L13a from Ribosome Silences Translation
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and released from the ribosome. At least two sequences
of induced release are possible: (1) ribosome bound
L13a is phosphorylated which causes release, or (2)
L13a dissociates from the ribosome and then is phos-
phorylated, causing a shift in the equilibrium away from
the ribosome bound form (Figure 6B). Free, phosphory-
lated L13a then binds the Cp 3-UTR GAIT element, and
possibly similar structural elements in other transcripts
(Sampath et al., 2003). Interaction of L13a, or an L13a-
containing GAIT complex, with the GAIT element si-
lences target mRNA translation (Figure 6C). Previously,
we have shown that silencing requires mRNA circular-
ization, or more precisely, the elements required for tran-
script closure, i.e., poly(A) tail, PABP, and eIF4G (Ma-
zumder et al., 2001). We have proposed that a function
of transcript circularization is to juxtapose the 3-UTR
binding protein with the 5-initiation site where it can
exert translational control (Mazumder et al., 2001, 2003).
The specific mechanism by which GAIT blocks transla-
tion-initiation has not been identified, but at least four
possibilities can be considered (Figure 6C). GAIT may
(1) inhibit function of the cap binding complex, eIF4F;
(2) block recruitment of the 43S preinitiation complex,
Figure 3. Translational Silencing Activity of Recombinant Human the mechanism responsible for inhibition of ferritin trans-
L13a
lation by iron-responsive protein-1 (Muckenthaler et al.,
(A) Expression of recombinant L13a by E. coli and insect cells.
1998); (3) prevent scanning of the 43S complex to theFull-length human L13a ORF cloned into pET-17b vector (or vector
initiation codon, the mechanism of inhibition of Dro-control, C) was used to transform E. coli BL21(DE3)pLysS that were
sophila msl-2 mRNA translation by sex-lethal (Gebauerinduced with IPTG. L13a cDNA was cloned into pFASTBAC1 and
expressed in High Five insect cells. Soluble recombinant L13a et al., 2003); or (4) block 60S ribosomal subunit joining,
(rL13a) in cell lysates was partially purified by size-exclusion chro- the mechanism of inhibition of 15-lipoxygenase transla-
matography. rL13a expression was shown by immunoblot analysis tion by hnRNP K and E1 (Ostareck et al., 2001).
with rabbit antihuman L13a antibody.
(B) Translational silencing activity of insect cell-derived L13a.
IFN--Inducible Phosphorylation of L13aCapped, Luc-Cp 3-UTR(50–150)-poly(A) cRNA was subjected to in vitro
translation in a reticulocyte lysate. The translation mixtures also L13a joins the list of other eukaryotic ribosomal proteins
contained cytosolic lysates (4 g) of partially purified, rL13a made that undergo phosphorylation (Lee et al., 2002; Remacha
by transformed E. coli or by baculovirus-infected insect cells. Trans- et al., 1995; Saenz-Robles et al., 1988; Diaz et al., 2002;
lation of capped, T7 gene 10 cRNA served as a specificity control.
Jefferies et al., 1997; Campos et al., 1990) or other post-A cytosolic lysate from U937 cells treated with IFN- for 24 hr served
translational modifications including ubiquitination (Fin-as a positive control for translational silencing activity.
ley et al., 1989; Spence et al., 2000), acetylation (Arnold
et al., 1999), and methylation (Lhoest et al., 1984). In
several cases, the modification regulates translation.for specificity, another 60S ribosomal protein, L28, was
found to be primarily associated with ribosomes at all The best-studied example is phosphorylation of the 40S
ribosomal subunit protein S6. Ribosomes containingtimes (Figure 5B). The absence of 28S and 18S ribosomal
RNA in the ultracentrifugal supernatant verified that the phosphorylated S6 exhibit a translational preference for
transcripts containing the 5-terminal oligopyrimidineprocedure efficiently removed all intact ribosome sub-
units (Figure 5C). Together these results show that upon sequence (Jefferies et al., 1997). Herpes simplex virus
induces S6 phosphorylation, which increases the effi-prolonged treatment of U937 cells with IFN-, L13a se-
lectively dissociates from the 60S ribosomal subunit as ciency of viral transcript translation (Masse et al., 1990).
A second case is phosphorylation of eukaryotic proteinsa free, phosphorylated protein capable of binding the
Cp 3-UTR GAIT element and silencing translation. P0, P1, and P2, which constitute the ribosomal stalk
that interacts with elongation factors during protein
translation (Ballesta et al., 1999). All are present in theDiscussion
phosphorylated form in ribosomes, but the function of
the modification is unclear. Mutagenesis studies in yeastWe have identified large ribosomal protein L13a as an
essential component in IFN--mediated, transcript- indicate that P0 phosphorylation is not necessary for
overall ribosome translational activity, but may influenceselective, translational silencing of Cp. Our results allow
us to propose a mechanism for L13a-mediated silencing the translation of specific mRNAs (Ballesta et al., 1999).
Likewise, the effects of phosphorylation of P1 and P2of translation. About 2–4 hr after treatment of U937 cells
with IFN-, Cp mRNA is induced and translation begins are transcript-specific, and complete deletion of these
genes in Saccharomyces cerevisiae results in only sub-(Mazumder et al., 1997; Mazumder and Fox, 1999); dur-
ing this period L13a is present in the nonphosphorylated tle changes in protein expression (Remacha et al., 1995).
A recent ribosome-wide survey of herpes simplex-form bound to 60S ribosomal subunits (Figure 6A). About
16–24 hr after IFN- treatment, L13a is phosphorylated infected HeLa cells showed phosphorylation of the 40S
Cell
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Figure 4. Regulation of L13a Expression and Phosphorylation by IFN- in U937 Cells
(A) IFN- treatment of U937 cells does not alter steady-state L13a mRNA expression. U937 cells were treated with IFN- for 8 or 24 hr. RNA
was isolated and subjected to Northern blot hybridization with full-length, radiolabeled human L13a cDNA as probe.
(B) IFN- treatment causes posttranslational modification of L13a. U937 cells were treated with IFN- for 8 or 24 hr and extracts were subjected
to SDS-PAGE using 12% polyacrylamide gel. Immunoblot analysis was done using polyclonal rabbit antihuman L13a antibody. The position
of modified L13a is indicated (open arrow).
(C) IFN- induces delayed phosphorylation of L13a in U937 cells. U937 cells were treated with IFN- and metabolically labeled with a 6 hr
pulse of 32P-orthophosphate. Lysates from labeled cells were immunoprecipitated with anti-L13a antibody or preimmune (Pre-im.) sera, and
immunoprecipitated protein was resolved by SDS-PAGE using 12% polyacrylamide gels and autoradiography. The position of phosphorylated
L13a (P-L13a) is indicated (open arrow).
(D) Alkaline phosphatase restores electrophoretic mobility of L13a. U937 cells were incubated with IFN- for 8 or 24 hr. Cytosolic extracts
from 24 hr-treated cells were treated with alkaline phosphatase (P-ase, 3 U) for 90 min and subjected to immunoblot analysis with anti-L13a
antibody. The position of phosphorylated L13a is indicated (open arrow).
(E) Alkaline phosphatase inhibits translational silencing activity of U937 cell extracts. Cytosolic extracts from IFN--treated cells were incubated
with alkaline phosphatase as in (A). Capped Luc-Cp(50–150)-poly(A) and T7 gene 10 cRNAs were subjected to in vitro translation in a rabbit
reticulocyte lysate as in Figure 2B.
(F) Phosphorylation of recombinant human L13a by baculovirus-infected insect cells. L13a expressing E. coli BL21(DE3)pLysS and baculovirus-
infected High Five cells, and their vector controls (vect.), were pulse-labeled for 4 hr with 32P-orthophosphate. Cell lysates were immunoprecipi-
tated with anti-L13a antibody followed by SDS-PAGE and autoradiography.
(G) Translational silencing activity of insect cell-derived L13a is phosphatase-sensitive. Capped Luc-Cp(50–150)-poly(A) and T7 gene 10 cRNAs
were subjected to in vitro. Partially purified, recombinant L13a (4 g) made by baculovirus-infected insect cells was treated with shrimp
alkaline phosphatase (P-ase, 3 U) in presence or absence of phosphatase inhibitor (P-ase inh.) cocktail for 90 min. After phosphatase treatment,
recombinant insect cell-derived L13a was added to the translation reaction. Translation of capped T7 gene10 cRNA was carried out in the
same reaction and served as a specificity control.
proteins S6, S2, Sa, and S3a, and a single 60S protein, vation. Furthermore, phosphorylation of ribosomal pro-
teins causes transcript-specific, rather than global,L30 (Diaz et al., 2002). Together these data suggest that
ribosomal protein phosphorylation (excluding P0, P1, translational regulation consistent with altered mRNA
selectivity not overall translational activity. The resultsand P2) is uncommon under basal conditions, but that
specific ribosomal proteins are modified upon cell acti- are also consistent with the recently proposed “ribo-
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Figure 5. IFN- Induces Release of L13a from the 60S Ribosomal
Subunit
(A and B) L13a is specifically released from ribosomes. U937 cells
were treated with IFN- for 8 or 24 hr. The cells were lysed in the
presence of cycloheximide and centrifuged at low speed. Ribo-
somes were precipitated by ultracentrifugation at 150,000  g for
2 hr through a sucrose cushion. To remove contaminating ribo-
somes, the supernatant was recentrifuged under the same condi- Figure 6. Model of L13a Release from Ribosomes and Its Role in
tions. Ribosome and nonribosome (cytosol) fractions were sub- Translational Silencing
jected to immunoblot analysis with anti-L13a (A) or with anti-L28 (A) Time  4 to 8 hr after IFN- addition: Cp mRNA is induced and
(B) antibodies. The positions of phosphorylated (open arrow) and efficiently translated. Circularization of transcript is mediated by 5-
unmodified (closed arrow) L13a are indicated. 3-interactions between PABP and poly(A) tail, and between PABP
(C) RNA was extracted from ribosomal and cytosolic fractions by and eIF4G.
Trizol and resolved on an agarose-formaldehyde gel under denatur- (B) Time  8 to 24 hr after IFN- addition: L13a is phosphorylated
ing conditions. Ribosomal RNA was visualized by ethidium bro- and released from the 60S ribosomal subunit. Phosphorylated L13a
mide staining. binds to the GAIT element, possibly in a complex with other cyto-
solic proteins.
(C) Time  24 hr after IFN- addition: 5-3-interactions juxtapose
GAIT, or the GAIT complex, with the translation-initiation regionsome filter hypothesis” in which structural differences
where it silences Cp mRNA translation by one of the following mech-among ribosomes in different cells, or under various
anisms: (1) inhibiting function of one or more components of the
conditions, leads to altered affinity for specific mRNAs cap binding complex, eIF4F; (2) blocking recruitment of the 43S
(Mauro and Edelman, 2002). preinitiation complex; (3) preventing scanning of the 43S complex
Phosphorylation of RNA binding proteins influences to the initiation codon; or (4) blocking 60S ribosomal subunit joining.
their binding to mRNA, which in turn influences tran-
script translation, stability, and processing (Siomi et al., tein kinase-interacting protein-1 increases dehydrin
2002; Ostareck-Lederer et al., 2002; Zhang et al., 2003; mRNA binding, mRNA stability, and transport (Li et al.,
Li et al., 2002; Dominski et al., 2002). For example, phos- 2002). The specific function of L13a phosphorylation is
phorylation of heterogeneous nuclear RNA binding pro- not known but, analogous to the examples above, it
tein K decreases binding to the 15-lipoxygenase 3-UTR may facilitate binding to the GAIT element, either directly
DICE element and derepresses translation (Ostareck- or via binding to other proteins in a GAIT element bind-
Lederer et al., 2002). In other examples, phosphorylation ing complex.
of Fragile X mental retardation protein-1 increases bind-
ing to specific transcripts and their translation (Zalfa et Release of L13a from the 60S Subunit: the
al., 2003; Siomi et al., 2002), phosphorylation of QKI Ribosome as a Depot for Translational
inhibits interaction with myelin basic protein mRNA and Control Proteins
increases transcript turnover (Zhang et al., 2003), and Our results show that phosphorylated L13a is present
as a ribosome-free cytosolic protein. Previous reportsphosphorylation of plant abscisic-acid-activated pro-
Cell
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Figure 7. Structure of L13, the Bacterial Ho-
molog of L13a, and Its Environment in the
50S Subunit of Haloarcula Marismortui
(A) Relationship of L13 to other 50S ribosomal
proteins and RNA. Space-filled, shadowed
model is generated using X-ray crystallo-
graphic coordinates (Ban et al., 2000). L13
(red) is adjacent to L3 (green) and L6 (blue)
on the RNA (white) surface. Other 50S pro-
teins are also shown (yellow).
(B) Same as (A), but RNA is depicted as
strands to reveal proteins in the interior of the
50S ribosome.
(C) Detail of 50S ribosome surface showing
relationship between L13a, L3, and L6.
(D) Same as (C) but L13 is removed from the
model to reveal underlying 23S RNA surface
(dashed outline).
of L13a are consistent with extra-ribosomal localization IFN- for 24 hr does not inhibit global protein synthesis,
as measured by metabolic labeling of protein withand function, for example, L13a is a tumor cell surface
antigen in mice (Sibille et al., 1990) and in human mela- [35S]methionine despite the complete absence of ribo-
some bound L13a (data not shown).noma cells (Li et al., 2001), and it is present in the cytosol
of fibroblasts (Li et al., 2001). In carcinoma cells, L13a The finding that liberation of ribosomal proteins does
not alter overall protein synthesis rate is consistent withinteracts with the heregulin receptor ErbB-3, a trans-
membrane kinase of the epidermal growth factor recep- recent studies of ribosome structure and function. Re-
cent evidence indicates that the ribosome is a ribozymetor family (Yoo and Hamburger, 1999). Interestingly,
IFN- activates ErbB-3 in a developmentally regulated in which catalysis, i.e., peptidyltransferase activity, is
conducted by the RNA (Noller et al., 1992; Maden et al.,fashion, and thus the receptor is a candidate for the
kinase that phosphorylates L13a (Kritzik et al., 2000). 1968). In support of this conclusion, X-ray crystallo-
graphic studies of the 50S subunit of Haloarcula maris-There is accumulating evidence for extra-ribosomal
functions of ribosomal proteins, particularly as partici- mortui show that most of the protein mass is present
as discrete globular domains on the surface of the RNApants in RNA translation and processing, and in DNA
replication, transcription, and repair (Wool, 1996; Wool core, far from the site of catalysis (Ban et al., 2000; Moore
and Steitz, 2003). Several proteins have extensions thatet al., 1996). Synthesis of E. coli ribosomal proteins is
regulated by an “autogenous control” mechanism in penetrate between the ribosomal RNA helices of multi-
ple domains and may contribute to structure stabiliza-which ribosomal proteins bind their own mRNA and in-
hibit translation of operons encoding groups of ribo- tion or to ribosome function. However, other 50S pro-
teins lack RNA-penetrating tails and appear to “float”somal proteins (Zengel and Lindahl, 1994). Similarly,
yeast ribosomal protein L30 and Thermus thermophilus on the RNA surface. None of these surface proteins have
been assigned a specific function in translation, andS15 autoregulate translation of their own transcripts by
binding to cis-acting elements that may mimic their potential extra-ribosomal functions remain largely elu-
sive. A comparable picture is emerging from lower reso-docking site in ribosomal RNA (Serganov et al., 2003;
Vilardell et al., 2000). Phosphoproteins P1 and P2 also lution structural studies of eukaryotic ribosomes (Spahn
et al., 2001). One interpretation of these data is thatexchange between the cytosol and the 60S subunit dur-
ing translation (Remacha et al., 1995). However, unlike some ribosomal proteins may represent an evolutionary
embellishment of the RNA core, adopted by the ribo-L13a phosphorylation, phosphorylation of P1 and P2
does not influence their interaction with ribosomes (Bal- some from preexisting proteins with defined functions
(Wool et al., 1996).lesta et al., 1999). In these cases, the protein released
from ribosomes influences translation of specific pro- Insight into possible mechanisms of ribosomal inter-
action and release of L13a can be gained from inspec-teins (or a group of proteins in the case of P1 and P2)
without altering global protein synthesis. We have found tion of L13, the bacterial homolog of eukaryotic L13a
(Ban et al., 2000). H. marismortui L13 is a globular proteina similar result for L13a; treatment of U937 cells with
Release of L13a from Ribosome Silences Translation
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Plasmid Constructionat the surface of the 50S subunit (Figure 7A). Visual
The bait RNA plasmid pRH3-Cp 3-UTR(50–150) used in the yeast three-replacement of the RNA in the space-filled model with
hybrid screen was made by PCR amplification of pcDNA3-Cp 3-strands does not expose any submerged L13 domains,
UTR (Mazumder and Fox, 1999) using appropriate Cp 3-UTR prim-
showing that it rests entirely on the surface and lacks ers also containing AvrII and XmaI sites. The amplified product
an RNA-penetrating extension (Figure 7B). L13 has only was cloned into the AvrII and XmaI sites of pRH3 (Invitrogen). The
construction of pcDNA3-Cp 3-UTR(50–150) was described previouslyminimal contact with domains of two nearby surface
(Sampath et al., 2003). PSP64-Luc-Cp 3-UTR(50–150)-poly(A) was usedproteins, L3 and L6 (Figure 7C). Removal of L13 from
to synthesize cRNA for in vitro translation, and was prepared fromthe model exposes a shallow depression in the RNA
PSP64-Luc-Cp 3-UTR-poly(A) (Mazumder et al., 2001). The parentalsurface and shows that L13 does not interact with any
construct was digested by StuI and XhoI, and the 247 bp 3-UTR
buried proteins (Figure 7D). The binding of ribosomal insert and the digested vector were gel-purified. The insert was
proteins to RNA is thought to depend on RNA surface amplified by PCR using primers to give a fragment spanning Cp 3-
UTR nucleotides 50–150, and containing StuI and XhoI sites. Thetopology and not specific RNA sequences (Moore and
fragment was ligated into the digested parental construct.Steitz, 2003). Also, L13 is far from the sites of chain
pET-17b-L13a and pFASTBAC1-L13a were used to express re-elongation and polypeptide exit, consistent with its lack
combinant human L13a in E. coli and insect cells, respectively. pET-of effect on global protein synthesis. Thus, the structure
17b-L13a was made by cloning the full-length ORF of human L13a
and position of L13 are consistent with unhindered re- into the Nde1 and BamH1 sites of pET-17b (Novagen, Madison, WI).
lease from the ribosome. Little is known about the struc- pFASTBAC1-L13a was made by cloning L13a into the BamH1 and
Xho1 sites of pFASTBAC1 (Invitrogen).ture and function of L13a in the eukaryotic 60S subunit.
Low-resolution analysis of the Saccharomyces cerevis-
Construction of U937 Cell cDNA Libraryiae 80S ribosome suggests that ribosomal protein L16,
for Yeast Three-Hybrid Screenthe yeast homolog of vertebrate L13a, is located at the
mRNA from U937 cells treated with IFN- for 8 and 24 hr was isolatedribosome surface (Spahn et al., 2001). Furthermore, a
and combined. The cDNA was synthesized by reverse transcription
protease sensitivity study of rat ribosomes suggests with oligodT-XhoI and random-XhoI primers, ligated with EcoR1
that surface exposure of L13a increases during chain adapters (DNA Technologies, Gaithersburg, MD), and treated with
elongation (Marzouki et al., 1990). XhoI and T4 polynucleotide kinase. Digested samples were sub-
jected to exclusion chromatography using Sephacryl S-400 (Phar-In summary, our results indicate that the ribosome, in
macia). Fractions containing DNA 400 bp or larger were pooled andaddition to functioning as a protein synthesis machine,
ligated to pYESTrp2 (Invitrogen), digested with EcoR1 and XhoI,also acts as a depot for releasable regulators of protein
and electroporated into E. coli DH5. The entire library was plated
translation. The function of delayed translational silenc- on ampicillin-containing plates after recovery in SOC media for 1
ing of Cp is not known. An attractive possibility is sug- hr. Colonies were scraped and resuspended in 15 ml of LB ampicillin
gested by the finding that Cp bactericidal activity is containing 15% glycerol, and frozen. Aliquots of the frozen stock
were regrown and plasmids representing the cDNA library wereeffective only in a narrow concentration range (Kleba-
isolated (Qiagen Miniprep Kit).noff, 1992). Alternatively, uncontrolled accumulation of
Cp in inflammatory sites may have injurious conse-
Yeast Three-Hybrid Screen for Cp 3-UTRquences consistent with the ability of Cp copper to oxi-
Interacting Proteinsdize lipoproteins (Ehrenwald and Fox, 1996; Mukhopad-
Saccharomyces cerevisiae strain L40uraMS2, that has the HIS3
hyay et al., 1997). The translational silencing mechanism gene under the control of LexA operon, and expresses the hybrid
may have evolved to terminate or limit macrophage ex- MS2 coat protein fused to LexA DNA binding domain, was cotrans-
formed with the plasmid pRH3-Cp 3-UTR(50–150) and pYESTrp2-pression of Cp and other inflammatory proteins. Inter-
cDNA library. The first plasmid expresses the Cp 3-UTR(50–150) baitestingly, several known mechanisms of inflammation-
RNA fused to MS2 RNA, and contains URA3 as auxotrophic marker.termination involve translational control (Kirkpatrick,
The second plasmid expresses prey proteins from IFN--treated2002). For example, long-term activation by IFN- may
U937 cells encoded by the cDNA library as a fusion protein with
have adverse consequences on the cellular environment the B42 activation domain and contains TRP1 gene as auxotrophic
and thus IFN- mRNA autoregulates its translation by marker. Double transformants were selected in medium deficient in
formation of an RNA pseudoknot (Ben-Asouli et al., histidine, uracil, and tryptophan, and to minimize false-positives
screening was done in the presence of 3-AT. To select for Cp 3-2002). Likewise, we speculate that macrophage prod-
UTR(50–150) RNA-dependent activation, positive clones were count-ucts of IFN- activation, e.g., Cp, may have injurious
erscreened in media lacking tryptophan and histidine but containingconsequences and require rapid downregulation.
uracil and 5-FOA, which causes rejection of the URA3-containing
bait plasmid. The cDNA inserts were amplified from 5-FOA-sensitiveExperimental Procedures
clones with pYESTrp2 vector primer pair and sequenced. Clones
containing the insert in-frame with the B42 activation domain wereReagents
selected and grown in tryptophan-deficient medium. The clonesRabbit reticulocyte lysate, methionine-minus amino acid mixture,
were harvested and lysed with glass beads in 50 mM Tris, [pH 7.6],and RNasin were purchased from Promega (Madison, WI). Human
50 mM NaCl, 1 mM phenylmethylsulfonyl fluoride (PMSF), and 1 mMIFN- was from R & D Systems (Minneapolis, MN). Trizol and Super-
dithiothreitol. Lysates were centrifuged at 10,000  g and superna-script were from Invitrogen (Gaithersburg, MD). Capped transcripts
tants collected for binding and activity measurements.were synthesized using Message Machine from Ambion (Austin, TX).
Translation-grade [35S]methionine was purchased from NEN-DuPont
Culture of U937 Cells and Preparation of Cytosolic Extracts(Boston, MA) and [32P]orthophosphate was from ICN (Costa Mesa,
Human U937 monocytic cells (American Type Culture Collection,CA). Rabbit polyclonal antibody against human ribosomal protein
Rockville, MD; CRL 1593.2) were cultured in RPMI 1640 mediumL28 was purchased from Santa Cruz (Santa Cruz, CA). Shrimp alka-
containing 10% fetal bovine serum. For preparation of cytosolicline phosphatase was from Fermentas. Phosphatase inhibitor cock-
extracts, 1 107 cells were preincubated for 1 hr in 10 ml of mediumtail set II (containing 1 M imidazole, 0.1 M sodium fluoride, 0.115 M
containing 2% fetal bovine serum and then IFN- (500 units/ml)sodium molybdate, 0.2 M sodium orthovanadate, and 0.4 M sodium
was added for up to 24 hr. The cells were collected by low-speedtartrate) was from Calbiochem (San Diego, CA). Levamisole and
other reagents were from Sigma (St. Louis, MO). centrifugation and suspended in 0.5 ml buffer containing 50 mM
Cell
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NaCl, 1 mM PMSF, 1 mM dithiothreitol, and 50 mM Tris, [pH 7.6]. chromatography. For immunoblot analysis, cell lysates were re-
solved by SDS-PAGE using 12% polyacrylamide gels and trans-The suspension was subjected to three freeze-thaw cycles, passed
several times through a 26 gauge needle, and centrifuged at ferred to Immobilon-P (Millipore) by a semidry transfer protocol. The
blot was probed with anti-L13a (1:5000) or anti-L28 antibody.100,000  g for 30 min. Supernatant protein concentration was
adjusted to 1 mg/ml and 4 g was used in the RNA EMSA and in
the in vitro translation reaction. Determination of In Vivo Interaction of L13a and Cp mRNA
The interaction of L13a with endogenous Cp mRNA was determined
by immunoprecipitation and RT-PCR. Lysates from IFN--treatedIn Vitro Transcription
Radiolabeled Cp 3-UTR(50–150) cRNA was prepared by in vitro tran- U937 cells (500 g protein in 150 mM NaCl, 1 mM EDTA, 1.5 mM
MgCl2, 0.05% Triton X-100, 50 mM HEPES, [pH 7.5]) were subjectedscription of XhoI-linearized pcDNA3-Cp 3-UTR(50–150) in the presence
of [-32P]UTP (MaxiScript kit, Ambion, TX) using T7 RNA polymerase. to immunoprecipitation using 10l of affinity-purified anti-L13a anti-
body. L13a-bound mRNA was isolated by Trizol extraction and sub-The transcript was purified on a 5% acrylamide gel containing urea.
For preparation of the 29 nt GAIT element (and the U87C mutant), jected to reverse transcription using oligo-dT primer (Superscript
kit, Invitrogen) and PCR amplification using a primer-pair specifictranscription templates were prepared by hybridizing complemen-
tary DNA oligomers corresponding to nt 78–106 of the Cp 3-UTR for amplification of the full-length, 247 nt Cp 3-UTR.
in buffer containing 1 mM EDTA, 0.1 M NaCl, and 10 mM Tris-HCl,
[pH 8.0]. The templates were engineered to contain the T7 promoter Metabolic Labeling of L13a by [32P]Orthophosphate
at the 5-end. Annealed, partially double-stranded templates were U937 cells (8  106 cells in 4 ml of RPMI 1640 medium) were treated
used for in vitro transcription using T7 RNA polymerase (MegaShort- with IFN- (500 units/ml) for up to 24 hr. The cells were collected by
Script, Ambion, TX). Unincorporated nucleotides were removed us- centrifugation at 7000  g, resuspended in phosphate-free medium
ing Micro Bio-spin P-30 columns (BioRad), and transcripts were (Invitrogen), and metabolically labeled with a 6 hr pulse of [32P]ortho-
purified by phenol/chloroform extraction and ethanol precipitation. phosphate. The cells were pelleted by centrifugation at 7000  g.
Luc Cp 3-UTR(50–150)-poly(A) cRNA was generated by linearizing The cells were lysed by suspension in 0.5% NP40, 50 mM NaCl, 1
PSP64-Luc Cp 3-UTR(50–150)-poly(A) using PvuII, and subjecting it to mM PMSF, 1 mM dithiothreitol, and 50 mM Tris, [pH 7.6], subjected
in vitro transcription using Sp6 polymerase (MegaScript, Ambion, to three freeze-thaw cycles, and passed several times through a 26
TX). The cRNA transcripts were capped by adding cap analog gauge syringe, and centrifuged at low speed to remove debris.
m7G(5)ppp(5)G and GTP at a 4:1 ratio (Message Machine, Ambion, L13a was immunoprecipitated from the supernatant using rabbit
TX). Capped, T7 gene 10 cRNA was made by in vitro transcription antihuman L13a (or preimmune serum) and protein A-Sepharose in
of pGEMEX-2 (Promega) by T7 RNA polymerase (Message Machine). buffer containing 150 mM NaCl, 0.5% Triton X-100, 0.5% sodium
Full-length cRNA transcripts were purified by electrophoresis on a deoxycholate, 0.1% SDS, 1 mM PMSF, and 50 mM Tris, [pH 7.6].
5% acrylamide gel containing 8 M urea. Proteins were resolved by 12% SDS-PAGE, and the gel dried and
allowed to expose MS film (Kodak, Rochester, NY). E. coli BL21(DE3)
pLysS transformed with the plasmid pET-17b-L13a and baculovirus-RNA Electrophoretic Mobility Shift Assay
[-32P]UTP-labeled Cp 3-UTR(50–150) or Cp 3-UTR(78–106) (20 fmol) was infected High Five insect cells transfected with the plasmid pFAST-
BAC1-L13a were metabolically labeled with [32P]orthophosphate us-incubated for 30 min at 4C with U937 cell extract (4 g of protein)
in 20 l of buffer containing 15 mM KCl, 0.25 mM DTT, 5 mM MgCl2, ing the same procedure but without IFN- treatment.
0.1 mM PMSF, 200 mg/ml of yeast tRNA, 40 U of RNasin, 10%
glycerol, and 12 mM HEPES, [pH 8.0]. In competition experiments, RNA Blot Analysis
unlabeled RNA segments were added to the extract at a 25-fold U937 cells (1  108 cells) were treated with IFN- for 8 or 24 hr,
molar excess 10 min before addition of radiolabeled probe. RNA- and total RNA was extracted with Trizol reagent (Invitrogen) and
protein complexes were resolved by native gel electrophoresis (5% subjected to polyA selection using an OligoTex mRNA kit (Qiagen,
polyacrylamide in 0.5  Tris-buffered EDTA) at 4C. The gel was Stanford, CA). The mRNA isolated from 100 g of total RNA was
dried and the probe position determined by autoradiography. fractionated on a 1% agarose-formaldehyde gel and transferred to
Nytran membranes (Schleicher and Schuell, Keene, NH). The blot
was hybridized with a random primer-labeled, full-length humanIn Vitro Translation of cRNA by Reticulocyte Lysate
For in vitro translation, gel-purified Luc Cp 3-UTR(50–150)-poly(A) L13a probe.
cRNA (200 ng) was added to 35 l of rabbit reticulocyte lysate,
20 M methionine-free amino acid mixture, 40 U RNasin, 20 Ci Ribosome Fractionation
translation-grade [35S]methionine, and U937 cell extract (4 g of Ribosome and nonribosome fractions were collected essentially as
protein) in a total volume of 50l for 60 min at 30C. To each reaction described (Wormington, 1991). In brief, U937 cells (5  108 cells)
was added cRNA encoding T7 gene 10 (100 ng) as a loading and were homogenized in 5 ml of buffer containing 20 mM Tris, [pH
specificity control. Oligonucleotide decoys were added at 50-fold 7.4], 10 mM MgCl2, 300 mM KCl, 10 mM dithiothreitol, 100 units/
molar excess. An aliquot (5 l) was resolved by SDS-PAGE using ml RNasin, and 100 g/ml cycloheximide. After centrifugation at
10% polyacrylamide. The gel was fixed, treated with Amplify (Amer- 10,000  g for 15 min to remove mitochondria and debris, the
sham), dried, and radiolabeled bands detected by autoradiography. supernatant was layered over a sucrose (20% w/v) cushion con-
taining cycloheximide and centrifuged at 149,000  g for 2 hr. The
ribosome-containing pellet and nonribosomal supernatant were col-Preparation of Recombinant L13a
E. coli BL21(DE3)pLysS (Novagen) were transformed with pET-17b- lected. To remove any ribosome contaminants, the supernatant was
subjected to a second centrifugation at 149,000  g. RNA wasL13a plasmid and induced with isopropyl -d-thiogalactoside
(IPTG). High Five insect cells (Invitrogen) were infected with pFAST- extracted from both fractions by Trizol and resolved in denaturing
1% agarose-formaldehyde gel. The gel was stained with ethidiumBAC1-L13a. Lysates were made from both L13a-expressing cells
and from cells expressing empty vectors as controls. The lysates bromide to visualize 18S and 28S RNA representing RNA in the 40S
and 60S subunits, respectively. For immunoblot analysis, ribosomewere partially purified by Sephadex G-200 size-exclusion chroma-
tography. Eluted fractions were monitored by Coomassie blue stain pellets were resuspended in Laemmli’s buffer and cytosolic frac-
tions were concentrated by vacuum centrifugation and mixed withand by immunoblot analysis using anti-L13a antibody.
Laemmli’s buffer.
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